Advertising


News

In Practice: Self-care for GPs


Matt Woodley


8/02/2024 4:28:24 PM

An upcoming webinar will discuss self-care strategies and explore the evidence-based benefits and nuances of mindfulness.

Female GP doing paperwork
A new webinar will discuss self-care strategies GPs can implement, as well as explore the evidence-based benefits and nuances of mindfulness.

This week’s In Practice also features information regarding a temporary shortage of the Nexium Hp7 composite pack, advance notice of a product discontinuation, details around the upcoming Australian Dementia Research Forum, a new vaping webinar, and the latest Zoomapalooza instalment.
 
Self-care for GPs
Webinar: Thursday 14 March, 7.00 – 8.30 pm (AEDT)
CPD: 1 EA
 
Self-care is vital for all GPs’ health and wellbeing. Looking after physical, mental, emotional, and social health can help to mitigate the risks of being affected by work-related stress, burnout, and mental health problems.
 
This webinar, presented by Dr Adele Stewart, accredited Mindfulness Based Stress Reduction Teacher and Chair of RACGP Specific Interests Pain Management, will discuss self-care strategies GPs can implement, and explore the evidence-based benefits and nuances of mindfulness.
 
Register online.
 
Temporary shortage of Nexium Hp7 composite packs
Due to a delay to an active ingredient, there is a temporary shortage of Nexium Hp7 (Esomeprazole 20 mg tablet [14], Amoxicillin 500 mg capsules [28], Clarithromycin 500 mg tablet [14]) composite packs.
 
AstraZeneca has said the temporary disruption to supply does not relate to any safety or efficacy concerns and anticipates that full supply will return from 15 April.
 
Those seeking more details on the shortage can contact AstraZeneca Medical Information via medinfo.australia@astrazeneca.com or 1800 805 342.
 
Advance notice of product discontinuation
Novo Nordisk will permanently cease the global manufacture and supply of Mixtard 30/70 InnoLet from July 2024.
 
The company is due to request that the medicine be deleted from the Pharmaceutical Benefits Scheme (PBS) from 1 August, while is also discontinuing Mixtard 30/70 Penfill from the PBS from 1 February 2025.
 
Several funded insulin alternatives are available and GPs seeking more information can contact the NovoCare Customer Care Centre via aunrccc@novonordisk.com or 0800 733 737.
 
Australian Dementia Research Forum
Date: 3–5 June
Location: JW Marriott Resort and Spa, Gold Coast
 
The Australian Dementia Research Forum (ADRF) brings together dementia researchers, health professionals and policymakers, as well as people living with dementia and their families and carers, to discuss the latest research, innovations, and best practices in dementia.
 
Five expert international and national speakers have been invited to deliver keynote addresses on topics spanning monoclonal antibodies, exercise physiology, neuroimaging, molecular causes of tauopathy in Alzheimer’s disease and dementia prevalence in specific communities.
 
Early bird registrations for discounted tickets are available for a limited time. 
 
Prescribing therapeutic vapes – overview of the regulatory changes
Webinar: Thursday 22 February, 5.30 7.00 pm (AEDT)
 
Find out the ‘why, when and how’ of prescribing therapeutic vapes.
 
The Therapeutic Goods Administration, in partnership with the RACGP and Quit Centre, is hosting an information session for prescribers on recent vaping reforms.
 
Medical and nurse practitioners will learn about the regulatory reforms and what the changes mean, as well as hear practical information on prescribing therapeutic vapes and strategies for supporting smoking and vaping cessation. It will also include a demonstration of the SAS/Authorised Prescriber online system. 
 
Register online.
 
Zoomapalooza
Webinar: Saturday 23 March, 10.00 am – 1.00 pm (AEDT)
CPD: 3 RP
Cost: $55
 
Join the Chairs of the Breast Medicine, Integrative Medicine and Social Prescribing RACGP Specific Interest groups, and gain valuable CPD reviewing performance hours at Zoomapalooza – three hours of online case-based discussion.

This session will be of particular interest for GPs involved in the care of patients undergoing breast cancer treatment, or in recovery, and will give attendees the opportunity to discuss how they can effectively manage these patients in general practice.
 
It will also explore the treatment pathways offered by integrative medicine and social prescription, and members are encouraged to bring along own patient cases to actively engage in discussion and collaborate with peers.
 
Register online.
 
Log in below to join the conversation.



dementia In Practice medication shortages self-care Zoomapalooza


Related



Advertising

Advertising


Login to comment